Refine by
Cancer Diagnosis Articles & Analysis
59 articles found
This method is particularly useful in identifying genetic abnormalities associated with cancer, such as gene amplifications, deletions, and translocations, which can play a critical role in the diagnosis and treatment planning of cancer patients. ...
This analysis encompasses the examination of biological tissues to understand their composition, organization, and pathology, which can be crucial for diagnosing diseases, particularly cancers. Understanding Histology Histology, the study of microscopic tissue structure, provides insights into the cellular makeup and organization of tissues. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. This significant advancement represents a vital leap in the quest for more precise and effective treatments for ovarian cancer. With the complexities of ovarian cancer treatment becoming ...
Colorectal cancer is one of the leading causes of cancer-related deaths globally. To advance our understanding of this disease and improve treatment strategies, researchers heavily rely on colorectal cancer cell lines. These cell lines serve as essential models for studying the biology of colorectal cancer, testing new therapies, and exploring the mechanisms of drug resistance. What are ...
This bionic nanostructure has proven effective for drug delivery, detoxification, photothermal treatment, imaging, cancer diagnosis, immune surveillance, vaccine design, etc. This paper presents the most recent research advances of cell membrane nanodrug delivery systems for bionic medicine. ...
Discover how matched tumor-normal sequencing can help clinical researchers detect the somatic origin of variants with certainty. In the era of precision oncology, it has become increasingly common for patients diagnosed with cancer to undergo tumor sequencing. Identifying the mutations that make up a tumor’s genomic landscape can help guide selection of targeted therapies and inform ...
Cancer diagnosis and management are evolving as researchers seek more precise solutions. ...
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. ...
Introduction CDH1, also known as E-cadherin, is a crucial protein involved in cell adhesion and plays a significant role in various biological processes. In recent years, researchers have focused on understanding the functions of CDH1 and its implications in cancer development. This blog post aims to shed light on what CDH1 protein does, its role in cancer, and the future research directions in ...
This platform enables antibody-mediated targeted delivery to achieve a high degree of tumor specificity, while using infrared light to activate the biophysical mechanism of the drug to accurately induce rapid death of cancer cells without harming surrounding normal tissue. In addition, NIR-PIT drugs can also be used as a supplement to PD-1 monoclonal antibodies, PD-L1 monoclonal ...
Elevated levels of PSA in the blood can indicate the presence of cancer, while a decrease in PSA levels can indicate that the cancer is responding to treatment. ...
ELISA is commonly used to diagnose infectious diseases, autoimmune disorders, and even cancer. Another enzyme-based diagnostic tool is polymerase chain reaction (PCR), which can detect and amplify small amounts of DNA or RNA in a patient's sample. ...
BioMark Diagnostics Inc. is a Canadian-based cancer diagnostic company with head office located in Richmond, British Columbia and operating lab in Quebec City, Quebec. ...
It is important for labs of all shapes and sizes to consider investing in the digital transformation process if they want to ensure they can keep pace with the challenges modern cancer diagnosis imposes upon strained pathologists. The Problems in Pathology Today First and foremost, pathologists today are facing increasing workloads. ...
While Movember is not just about prostate cancer, it is a great place to start; prostate cancer is the second most common cancer among men worldwide1, and the second leading cause of cancer death in American men.2 In the UK, more than 52,000 men are diagnosed with prostate cancer every year on average – ...
CASE PRESENTATION A 70-year-old female recently diagnosed with metastatic pancreatic cancer presented with acute new onset of lower back pain. The patient was taking chemotherapy, participating in a drug therapy trial, and had received radiation therapy. There was no history of acute trauma to the pelvic or acetabular region. Magnetic resonance imaging revealed bilateral fragility fractures, with ...
Prior to her diagnosis, she was a caretaker for her husband who is currently managing a rare blood disorder. ...
The day a person receives a cancer diagnosis is likely one of the worst days of their lives. For some new patients, the typical approach may be to seek care from a specialist at an NCCN-designated cancer center. But for the majority of Americans, it will be a community oncologist who guides them through their cancer ...
Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol, “OCEA”. PROVIDENCE, R.I. and NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ocean Biomedical and Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) ...
Futura Medical (LON: FUM) says that the clinical study for the MED3000 topical gel erectile dysfunction treatment has met its primary and secondary endpoints. They showed an improvement in erectile function and a highly statistic improvement in the onset of action at 10 minutes. There were limited side effects with 4.3% of patient suffering headaches and a further 4.3% nausea, which is much ...